Lawrence M. Alleva, Director at Mersana Therapeutics, Inc. (MRSN), bought 1,085 shares at $22.97 ($25K) on 2020-06-01, disclosed to the SEC on 2020-06-03.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.94 | 700 | $16K | 64.5% |
| 2 | $22.97 | 385 | $9K | 35.5% |
| Total | $22.95 avg | 1,085 | $25K | 100% |
| Filing → |
| GRTX | BUY | 2021-06-03 | $35K | — | Filing → |
| MRSN | BUY | 2021-06-03 | $15K | — | Filing → |
| GRTX | BUY | 2020-11-17 | $24K | — | Filing → |